Genetic and pharmacogenetic analyses of patients with epilepsy and related diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025480

Enrollment

1200

Registered

2021-09-17

Start date

2021-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40 F45.0

Interventions

Group 1: Clinical data and DNA samples will be collected continuously throughout the study period.

Eligibility

Sex/Gender

All

Age

0 Years to 105 Years

Inclusion criteria

Inclusion criteria: - Individuals with diagnosis of epilepsy syndrome or related paroxysmal disorder - 1st and 2nd degree relatives of individuals with diagnosis of epilepsy syndrome or related paroxysmal disorder

Exclusion criteria

Exclusion criteria: Individuals who are not able to give informed consent by themselves or by a legal guardian

Design outcomes

Primary

Measure	Time frame
Genetic analysis of collected samples.	—

Secondary

Measure	Time frame
Identification of genetic variants for further functional studies.	—

Countries

Germany

Contacts

Public ContactStefan Wolking

Universitätsklinikum der RWTH Aachen

swolking@ukaachen.de0241-80-85829

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026